SDC-1801

N/A

Report date: 2022/04/19 14:27:33
NME

Base Information

Drug NameSDC-1801
Drug Alias NameSDC-1801
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase 2 inhibitorsTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase 2Tyrosine-protein kinase JAK1
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Autoimmune DiseasesPsoriasis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSareum
China Registration ClassN/A

Develop Information

Active CompaniesSareum
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Autoimmune DiseasesPsoriasis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A